During the past decade, Bernstein Clinical Research Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 19 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 11 clinical trials were completed. i.e. 52.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bernstein Clinical Research Center" #1 sponsor was "Meda Pharmaceuticals" with 9 trials, followed by "Shire" with 9 trials sponsored, "Aimmune Therapeutics, Inc." with 3 trials sponsored, "ARS Pharmaceuticals, Inc." with 2 trials sponsored and "Abionic SA" with 2 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bernstein Clinical Research Center" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Johns Hopkins University" with 2 trials as a collaborator, "NAMSA" with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator and "Bernstein Clinical Research Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Bernstein Clinical Research Center" are "Asthma" (11 trials), "Hereditary Angioedema (HAE)" (6 trials), "Hereditary Angioedema" (5 trials), "Seasonal Allergic Rhinitis" (5 trials) and "Eosinophilic Esophagitis" (3 trials). Many other conditions were trialed in "Bernstein Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Bernstein Clinical Research Center" are "Drug" (44 trials), "Biological" (15 trials), "Other" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "AR101" (3 trials), "Omalizumab" (3 trials), "fluticasone propionate" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bernstein Clinical Research Center" are 61 trials for "All" genders.

Currently, there are NaN active trials in "Bernstein Clinical Research Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Bernstein Clinical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bernstein Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".